Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
nepafenac (nevanac) (1 trial)
Edema (Phase 2)
Macular Edema (Phase 2)
Trials (1 total)
Trial APIs (1 total)